As per our report, the size of the global contrast injector market was worth USD 524.10 million in 2020 and is projected to be growing at a CAGR of 8.1% and will reach USD 773.65 million by 2025.
The contrast injector is used to inject contrast media or contrast agents into the blood to increase the contrast of the structure of fluids within the body in medical imaging. The contrast media absorb or alter the external electromagnetism or the ultrasound and give an accurate image in medical imaging. Contrast media are commonly used to improve the visibility of blood vessels and the gastrointestinal tract. There are different contrasts media used in medical imaging, depending on the type of medical imaging. Automation injection system helps to deliver a precise amount of contrast.
The injection of contrast media enables visualization of various ailments through X-ray, computed tomography, magnetic resonance, or other different medical-imaging modalities into the blood-stream. The delivery of contrast media is considered most effective by the implementation of a medical device for this purpose, known as a contrast injector or power injector.
Plungers, in contrast injectors, push the contrast media into the tubing connected to a patient’s vascular system. Contrast injectors are controlled by a computer-controlled unit in the room, where volumes and flow rates of the media are programs and, the start & stop mechanisms are controlled. The device can be programmed to deliver specific amounts of contrast agents at accurate flow rates.
MARKET DRIVERS
The growing number of contrast agent approvals, developments in the technology increasing funding by the governments are primarily propelling the global contrast injector market.
The use of medical imaging in the healthcare sector is increasing the demand for more accurate imaging, which is estimated to support the growth of the global contrast injector market. Growing awareness over the benefits in the utilization of these injectors is enhancing the demand of the market. Increasing investments on the development of innovative products in healthcare are likely to bolster the growth rate of the market. The key players in the market are using different software and I.T. to improve the technological solutions, which is offering growth scope to the market.
MARKET RESTRAINTS
The shortage of trained and skilled professional to operate is also impeding the demand of the market. Some people experience rash, skin redness, vomiting, or dizziness which could last for one hour or longer with the regular use of contrast injector, which is projected to hamper the growth rate of the contrast injector market to some extent.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analyzed |
By Product, Application and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analyzed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report on the global contrast injector market has been segmented and sub-segmented based on the product, application and region.
Contrast Injector Market - By Product
Based on the product, the consumables segment is expected to have the highest growth during the forecast period. Growing necessities of consumables to conserve welfare and sterilized conditions during the diagnostic processes are majorly attributing the market growth.
The injector systems are followed after the consumable segment in showcasing quickest growth. The injectors system is further sub-segmented into CT injectors, MRI injectors and Angiography injectors, in which, the CT injectors segment is estimated to display a lucrative growth rate during the forecast period.
Contrast Injector Market - By Application
Based on the application, the radiology segment is anticipated to hold the largest share of the global contrast injector market during the forecast period. The growth is accredited due to the increasing number of radiology procedures which uses contrast media. This segment is estimated to produce profitable growth due to demand for non-invasive medical imaging techniques.
The interventional cardiology segment is projected to have the quickest growth rate during the period. The growth is due to an average increase in cardiac diseases such as stroke, heart attack, and heart valve problems.
Contrast Injector Market - By Region
As of 2019, North America leads the market, accounting for the significant global market share, with the U.S. accounting for the considerable share. Europe comes in second in terms of market share. However, Asia-Pacific is expected to expand at the highest CAGR during the forecast period majorly because of the increasing feasibility of approvals for the use of contrast media and the market potential offered by the region to companies producing contrast injectors.
TOP COMPANIES IN THE MARKET
The key companies in the global contrast injector market profiled in the report are Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), Ulrich GmbH & Co. K.G. (Germany), G.E. Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo R.T. Co., Ltd. (China).
RECENT MARKET DEVELOPMENTS
On April 21 2020, Guerbet announced that it received US FDA approval for manufacturing of Dotarem injection.
On December 24 2019, the Bayer AG Leverkusen Germany launched its new MEDRAD Stellent FLEX CT injection system. It helps to control the administration of intravenous C.T. contrast media.
On November 4 2019, G.H. Healthcare announced US FDA approval for macrocyclic MRI contrast agent clariscan. It is a gadolinium-based contrast agent.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Injector Systems
5.1.2.1 CT Injector Systems
5.1.2.2 MRI Injector Systems
5.1.2.3 Angiography Injector Systems
5.1.3 Consumables
5.1.3.1 Injector Heads
5.1.3.2 Syringes
5.1.3.3 Tubing
5.1.3.4 Other Consumables
5.1.4 Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Radiology
5.2.3 Interventional Cardiology
5.2.4 Interventional Radiology
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Bracco Imaging S.p.A.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bayer HealthCare
8.3 Guerbet Group
8.4 Medtron AG
8.5 ulrich GmbH & Co. KG
8.6 GE Healthcare
8.7 AngioDynamics
8.8 Nemoto Kyorindo Co.
8.9 Sino Medical- Device Technology
8.10 VIVID IMAGING
8.11 Apollo RT Co.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
